In preclinical studies, GIP and GLP1 reduce atherosclerosis
Generally, we define some microbiota that is beneficial to the stability of microbiota as probiotics, which can enhance the intestinal barrier function, reduce inflammatory reaction and stabilize the intestinal microbiota
When you take a product designed for bioavailability, you are being more efficient with your resources
Injection Site Reactions : Mild redness, itching, or swelling at the injection site
There is no approved evidence for human use
Relevant clinical trials should assess outcomes such as sleep-onset latency, total sleep time, wakefulness after sleep onset, sleep efficiency, daytime functioning and patient-reported symptoms